Anthropic Faces Lawsuit Over Misleading Claude Pricing
A new class-action alleges that Anthropic overstated Claude Max usage limits and the promised savings. The case could...
A budget review helps you spot gaps and realign spending with goals. This introduction highlights essential items to include for a clear, actionable assessment.
17,603 articlesA new class-action alleges that Anthropic overstated Claude Max usage limits and the promised savings. The case could...
As Nvidia captures headlines with its chips, two AI software plays are quietly building durable demand. This article ...
A SpaceX IPO frenzy can tempt investors to pay too much for one stock. Learn why a diversified space ETF, around $34,...
When you start taking required minimum distributions (RMDs), a simple mistake can ripple into bigger tax bills, highe...
New York launches a year-long study to evaluate a possible co-host Winter Olympics with Lake Placid and NYC. The move...
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
As Anthropic prepares for a public debut, many investors seek exposure to AI beyond private rounds. The AGIX ETF offe...
Sandisk has surged as AI infrastructure gains grab headlines. But can the rally last? This article lays out 3-year sc...
When a tech stock dives 84%, it can feel like a lost cause. This guide shows a disciplined way to assess beaten-down ...
Pfizer's stock has lagged since 2021, but the story isn’t over. This guide breaks down why pfizer stock: still priced...
Palantir’s business is booming, yet its stock has struggled. This article breaks down why growth and stock moves aren...
A public moment about a family member sparks online debate and real questions about money, governance, and legacy. He...